Robert Octave Westcot Ii, MD in Biddeford, ME - Medicare Ophthalmology

Robert Octave Westcot Ii, MD is a medicare enrolled "Ophthalmology" physician in Biddeford, Maine. He went to University Of Vermont College Of Medicine and graduated in 1980 and has 44 years of diverse experience with area of expertise as Ophthalmology. His current practice location is 22 West Cole Road, Biddeford, Maine. You can reach out to his office (for appointments etc.) via phone at (207) 284-5880.

Robert Octave Westcot Ii is licensed to practice in Maine (license number 012847) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013986033.

Contact Information

	Robert Octave Westcot Ii, MD
	22 West Cole Road, Biddeford, ME 04005-9430
	(207) 284-5880
	(207) 283-1543

Physician's Profile

Full Name	Robert Octave Westcot Ii
Gender	Male
Speciality	Ophthalmology
Experience	44 Years
Location	22 West Cole Road, Biddeford, Maine
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Robert Octave Westcot Ii attended and graduated from University Of Vermont College Of Medicine in 1980

NPI Data:

NPI Number: 1013986033
Provider Enumeration Date: 03/14/2006
Last Update Date: 02/03/2022

Medicare PECOS Information:

PECOS PAC ID: 7911940721
Enrollment ID: I20050602000842

Medical Identifiers

Medical identifiers for Robert Octave Westcot Ii such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013986033	NPI	-	NPPES
126680000	Medicaid	ME

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	012847 (Maine)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Southern Maine Health Care	Biddeford, ME	Hospital

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert Octave Westcot Ii is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robert Octave Westcot Ii, MD 22 West Cole Road, Biddeford, ME 04005-9430 Ph: (207) 284-5880	Robert Octave Westcot Ii, MD 22 West Cole Road, Biddeford, ME 04005-9430 Ph: (207) 284-5880

News Archive

Parents report increase in child's emotional difficulties during COVID-19 lockdown

Parents/carers of children aged 4-10 years of age reported that over a one-month period in lockdown, they saw increases in their child's emotional difficulties, such as feeling unhappy, worried, being clingy and experiencing physical symptoms associated with worry, according to early results from the Co-SPACE study, asking parents and carers about their children's mental health through the COVID-19 crisis.

RadNet completes acquisition of Health Diagnostics' New Jersey subsidiary

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today reported it has completed the previously announced acquisition of the New Jersey operating subsidiary of Health Diagnostics.

Public-health approach for HIV control in India needs to become more scientific

The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.

Extending hepatitis C treatment for liver transplant patients results in sustained viral clearance

Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study.

Robert Octave Westcot Ii, MD - Medicare Ophthalmology in Biddeford, ME